Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Johnson and Johnson
McKinsey
Express Scripts
Mallinckrodt

Last Updated: December 11, 2019

DrugPatentWatch Database Preview

Litigation Details for EAGLE VIEW TECHNOLOGIES, INC. v. XACTWARE SOLUTIONS, INC. (D.N.J. 2015)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

EAGLE VIEW TECHNOLOGIES, INC. v. XACTWARE SOLUTIONS, INC. (D.N.J. 2015)

Docket   Start Trial Date Filed 2015-09-23
Court District Court, D. New Jersey Date Terminated 2019-09-26
Cause 35:271 Patent Infringement Assigned To Renee Marie Bumb
Jury Demand Both Referred To Joel Schneider
Parties EAGLE VIEW TECHNOLOGIES, INC.; PICTOMETRY INTERNATIONAL CORP.; VERISK ANALYTICS, INC.; XACTWARE SOLUTIONS, INC.
Patents 10,029,011; 10,086,010; 7,265,009; 9,108,015
Attorneys ELEONORE OFOSU-ANTWI; ELINA SLAVIN; HECTOR DANIEL RUIZ; LIZA M. WALSH; MARK H. ANANIA; MATTHEW ADAM SKLAR; OLGA UGOLEV; RAVIN R. PATEL; READE WILLIAM SELIGMANN; SCOTT S. CHRISTIE
Firms Alston & Bird LLP; McCarter & English LLP; McCarter & English, LLP; McCarter and English, LLP; Ravin R. Patel; Saul Ewing Arnstein & Lehr LLP
Link to Docket External link to docket
Small Molecule Drugs cited in EAGLE VIEW TECHNOLOGIES, INC. v. XACTWARE SOLUTIONS, INC.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in EAGLE VIEW TECHNOLOGIES, INC. v. XACTWARE SOLUTIONS, INC.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for EAGLE VIEW TECHNOLOGIES, INC. v. XACTWARE SOLUTIONS, INC. (D.N.J. 2015)

Date Filed Document No. Description Snippet Link To Document
2019-06-03 674 22:19 29:6 29:10 29:11 29:25 SP,R …#39;436 patent, the '840 patent, and the '376 patent. 149. The Sungevity patent claims…the '436 patent, Claims 10 and 18 of the '840 patent, Claim 12 of the '770 patent, Claim …;436 patent, Claims 10 and 18 of the '840 patent, Claim 12 of the '770 patent, Claim…;436 patent, Claims 10 and 18 of the '840 patent, Claim 12 of the '770 patent, Claim External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Baxter
Johnson and Johnson
Mallinckrodt
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.